Qualitative Interviews with Patients Diagnosed with Fabry Disease
Research type
Research Study
Full title
Qualitative Interviews with Patients Diagnosed with Fabry Disease (Treatment Naïve)
IRAS ID
170485
Contact name
Janet Selby-Sievewright
Contact email
Sponsor organisation
Genzyme Corporation
Clinicaltrials.gov Identifier
RRK5162 , UHB R+D ref
Duration of Study in the UK
0 years, 2 months, 30 days
Research summary
The study sponsor is interested in the assessment of patient reported outcomes (PRO) in Fabry disease.
The purpose of this study is to learn more about the symptoms experienced by persons with Fabry disease in order to develop a better patient reported questionnaire for use in future studies about Fabry disease. The information collected will be used to finish the development of a new questionnaire for use in future clinical trials.
REC name
West Midlands - Edgbaston Research Ethics Committee
REC reference
15/WM/0033
Date of REC Opinion
13 Feb 2015
REC opinion
Further Information Favourable Opinion